stoxline Quote Chart Rank Option Currency Glossary
  
iRhythm Technologies, Inc. (IRTC)
142.69  0.25 (0.18%)    05-23 16:00
Open: 140.84
High: 143.925
Volume: 333,568
  
Pre. Close: 142.44
Low: 140.25
Market Cap: 4,555(M)
Technical analysis
2025-05-23 4:48:48 PM
Short term     
Mid term     
Targets 6-month :  168.1 1-year :  196.34
Resists First :  143.92 Second :  168.1
Pivot price 139.32
Supports First :  115.02 Second :  97.16
MAs MA(5) :  141.59 MA(20) :  132.48
MA(100) :  110.2 MA(250) :  93
MACD MACD :  8.8 Signal :  8.8
%K %D K(14,3) :  93.7 D(3) :  95.2
RSI RSI(14): 80
52-week High :  143.92 Low :  55.91
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ IRTC ] has closed below upper band by 15.3%. Bollinger Bands are 49.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 144.06 - 144.61 144.61 - 145.25
Low: 138.75 - 139.34 139.34 - 140.02
Close: 141.58 - 142.54 142.54 - 143.64
Company Description

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Headline News

Thu, 22 May 2025
Demystifying iRhythm Technologies: Insights From 6 Analyst Reviews - Benzinga

Thu, 22 May 2025
iRhythm Technologies (IRTC) Sees Price Target Hiked by Citigroup - GuruFocus

Wed, 21 May 2025
iRhythm Technologies Lines Up Triple Conference Schedule: William Blair, Goldman Sachs, and Truist Securities - Stock Titan

Wed, 21 May 2025
IRTC SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Thu, 15 May 2025
iRhythm Technologies, Inc. (NASDAQ:IRTC): Is Breakeven Near? - simplywall.st

Sun, 11 May 2025
Why iRhythm Technologies (IRTC) Is Among the Best Performing Healthcare Stocks to Buy Now - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 32 (M)
Shares Float 32 (M)
Held by Insiders 1 (%)
Held by Institutions 111.2 (%)
Shares Short 3,120 (K)
Shares Short P.Month 2,920 (K)
Stock Financials
EPS -3.14
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.71
Profit Margin -15.9 %
Operating Margin -19.5 %
Return on Assets (ttm) -4.4 %
Return on Equity (ttm) -111.2 %
Qtrly Rev. Growth 20.2 %
Gross Profit (p.s.) 13.44
Sales Per Share 19.37
EBITDA (p.s.) -1.83
Qtrly Earnings Growth 0 %
Operating Cash Flow 48 (M)
Levered Free Cash Flow 27 (M)
Stock Valuations
PE Ratio -45.59
PEG Ratio 0
Price to Book value 52.65
Price to Sales 7.36
Price to Cash Flow 95.85
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android